We are live on ! Find out more
RJA

Raymond James & Associates Portfolio holdings

AUM $164B
1-Year Est. Return 33.91%
This Fund
S&P 500
This Quarter Est. Return
+8.94%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+436.07%
AUM
$124B
AUM Growth
+$12.6B
Cap. Flow
+$4.01B
Cap. Flow %
3.23%
Top 10 Hldgs %
24.28%
Holding
4,396
New
293
Increased
2,114
Reduced
1,559
Closed
268

Sector Composition

Rank Sector Weight
1 Technology 15.45%
2 Financials 8.54%
3 Healthcare 8.18%
4 Consumer Discretionary 6.58%
5 Industrials 6.24%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HZON
4276
DELISTED
Horizon Acquisition Corporation II
HZON
-28,616
Closed -$280K
AGRX
4277
DELISTED
Agile Therapeutics
AGRX
-13
Closed -$25K
APEN
4278
DELISTED
Apollo Endosurgery, Inc.
APEN
-28,392
Closed -$257K
ISDX
4279
DELISTED
Invesco Exchange-Traded Self-Indexed Fund Trust Invesco RAFI Strategic Developed ex-US ETF
ISDX
-9,286
Closed -$279K
ONEM
4280
DELISTED
1Life Healthcare
ONEM
-10,155
Closed -$206K
WEBR
4281
DELISTED
Weber Inc.
WEBR
-11,747
Closed -$207K
BIOR
4282
DELISTED
Biora Therapeutics, Inc. Common Stock
BIOR
-88
Closed -$33K
QTNT
4283
DELISTED
Quotient Limited Ordinary Shares
QTNT
-259
Closed -$24K
SRLP
4284
DELISTED
SPRAGUE RESOURCES LP
SRLP
-10,890
Closed -$203K
RMO
4285
PUT
DELISTED
Romeo Power, Inc.
RMO
-10,500
Closed -$81K
TPGY
4286
DELISTED
TPG Pace Beneficial Finance Corp.
TPGY
-21,151
Closed -$223K
CNVY
4287
DELISTED
Convey Health Solutions Holdings, Inc.
CNVY
-10,100
Closed -$85K
ATHX
4288
DELISTED
Athersys, Inc. Common Stock
ATHX
-564
Closed -$19K
FST
4289
DELISTED
FAST Acquisition Corp.
FST
-58,981
Closed -$750K
DYFN
4290
DELISTED
Angel Oak Dynamic Financial Strategies Income Term Trust
DYFN
-9,800
Closed -$200K
GPL
4291
DELISTED
Great Panther Mining Limited
GPL
-2,000
Closed -$9K
IRCP
4292
DELISTED
IRSA Propiedades Comerciales S.A.
IRCP
-10,899
Closed -$32K
SRGA
4293
DELISTED
Surgalign Holdings, Inc. Common Stock
SRGA
-2,273
Closed -$74K
EVFM
4294
DELISTED
Evofem Biosciences, Inc. Common Stock
EVFM
-1,217
Closed -$13K
HBP
4295
DELISTED
Huttig Building Products, Inc.
HBP
-26,351
Closed -$140K
FMAC.U
4296
DELISTED
FirstMark Horizon Acquisition Corp. Units, each consisting of one share of Class A common stock and
FMAC.U
-18,000
Closed -$183K
BTNB
4297
DELISTED
Bridgetown 2 Holdings Limited Class A Ordinary Shares
BTNB
-11,105
Closed -$110K
JPN
4298
DELISTED
Xtrackers Japan JPX-Nikkei 400 Equity ETF
JPN
-9,295
Closed -$315K
CSLT
4299
DELISTED
CASTLIGHT HEALTH, INC.
CSLT
-13,400
Closed -$21K
GTS
4300
DELISTED
Triple-S Management Corporation
GTS
-8,845
Closed -$313K

Similar funds

Raymond James & Associates's Q4 2021 Portfolio in Review

As of Q4 2021, Raymond James & Associates held 4,396 positions worth $124B, up 11% from $111B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Raymond James & Associates deployed $4.01B of net new capital in Q4 2021, opening 293 new positions and adding to 2,114 existing holdings. Its largest new stake was Wells Fargo 7.5% Non Cumv Perp Conv: 14,614 shares worth $21.8M.

By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 15% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was iShares MSCI All Country Asia ex Japan ETF, an estimated $80M trimmed.

  • Raymond James & Associates's largest Q4 2021 buy was Wells Fargo 7.5% Non Cumv Perp Conv: 14,614 shares worth $21.8M.
  • Raymond James & Associates added most to iShares Core US Aggregate Bond ETF in Q4 2021, an estimated $212M increase.
  • Raymond James & Associates's biggest Q4 2021 reduction was iShares MSCI All Country Asia ex Japan ETF, cutting an estimated $80M.
  • Raymond James & Associates fully exited Kansas City Southern in Q4 2021, selling an estimated $80.8M.
  • Raymond James & Associates's ten largest holdings make up 24% of its $124B portfolio in Q4 2021.
  • Raymond James & Associates opened 293 new positions and closed 268 in Q4 2021.
  • Raymond James & Associates's portfolio value rose 11% quarter-over-quarter to $124B.

Based on Raymond James & Associates's 13F filing for Q4 2021, filed 8 Feb 2022.